<DOC>
	<DOC>NCT00660335</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and effectiveness of RG1068 (synthetic human secretin) with MRCP in subjects with abnormalities of the pancreas.</brief_summary>
	<brief_title>Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas</brief_title>
	<detailed_description />
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Secretin</mesh_term>
	<criteria>History of pancreatitis Medically stable Able to give informed consent Prior history of pancreatic resection Prior history of pancreatic duct drainage procedure Presence of a pancreatic stent Unstable cardiovascular disease Any contraindication to MRI procedure Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>secretin, RG1068, MRCP, pancreas</keyword>
</DOC>